FTLF FITLIFE BRANDS, INC.

Nasdaq Medicinal Chemicals & Botanical Products NV CIK: 0001374328
AI RATING
STRONG_SELL
85% Confidence

Investment Thesis

FitLife Brands faces acute financial distress with a catastrophic 75% YoY revenue decline, leaving the company vulnerable despite maintaining positive profitability and cash flow. The combination of $46.5M long-term debt against only $1.2M cash reserves and $45.4M equity creates an unsustainable capital structure. Refinancing risk is elevated and the company's ability to service debt and fund operations is increasingly compromised.

Strengths

  • + Positive free cash flow of $2.5M despite revenue collapse shows ability to preserve cash
  • + Gross margin of 37.6% remains stable, indicating pricing power in core product line
  • + Interest coverage ratio of 7.4x demonstrates current ability to service debt obligations

Risks

  • ! Severe revenue decline of 75.3% YoY indicates fundamental business deterioration or market loss
  • ! Critical liquidity crisis with only $1.2M cash against $46.5M debt and 1.02x debt-to-equity ratio creates refinancing and covenant violation risk
  • ! Quick ratio of 0.49x reveals heavy inventory dependence; company may struggle to meet short-term obligations if sales continue declining
  • ! Zero capital expenditure suggests operational retrenchment; minimal investment capacity for growth or competitiveness

Key Metrics to Watch

Financial Metrics

Revenue
25.3M
Net Income
1.7M
EPS (Diluted)
$0.17
Free Cash Flow
2.5M
Total Assets
104.3M
Cash
1.2M

Profitability Ratios

Gross Margin 37.6%
Operating Margin 12.1%
Net Margin 6.8%
ROE 3.8%
ROA 1.6%
FCF Margin 9.8%

Balance Sheet & Liquidity

Current Ratio
1.52x
Quick Ratio
0.49x
Debt/Equity
1.02x
Debt/Assets
56.5%
Interest Coverage
7.39x
Long-term Debt
46.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-16T09:11:14.942111 | Data as of: 2026-03-31 | Powered by Claude AI